Effect of hypercholesteremia on vascular endothelial funcion and albumin excretion rate in patients with diabetes mellitus

Japanese Journal of Nephrology

Volumn 38, Issue 11, 1996, Pages 507-512

  Nakano, Hirofumi ^a   Yamada, Kenichi ^b   Nishimura, Motonobu ^a   Miura, Yasuhiko ^a   Suzuki, Satoshi ^a   Wakabayashi, Yoshinori ^a   Tuchida, Hiroki ^a   Shibasaki, Toshiaki ^c   Sakai, Osamu ^c  

^a SAKURA NATIONAL HOSPITAL   (Japan)

^b Division of Clinical Research   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Endothelial dysfunction; Hypercholesteremia; Tissue type plasminogen activator (tPA); Von Willebrand factor (vWF)

Indexed keywords

DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN; SIMVASTATIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ALBUMINURIA; ARTICLE; BLOOD; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ALBUMINURIA; ANTICHOLESTEREMIC AGENTS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGED; SIMVASTATIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0030280744     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36, 1990
2. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ: Imparied vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228-234, 1990
3. Drexler H, Zeiher AM, Meinzer K, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338: 1546-1550, 1991
4. Haak T, Marz W, Jungmann E, Hausser S, Siekmeier R, Gross W, Usadel KH: Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Invest 72: 580-584, 1994
5. Tanaka A, Ishii H, Hiraishi S, Kazama M, Maezawa H: Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem 37: 269-272, 1991
6. Iwashima Y, Sato T, Watanabe K, Ooshima E, Hiraishi S, Ishii H, Kazama M, Makino I: Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39: 983-988, 1990
7. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340: 319-323, 1992
8. Stehouwer CD, Stroes ES, Hackeng WH, Mulder PG, den Ottolander GJ: von Willebrand factor and development of diabetic nephropathy in IDDM. Diabetes 40: 971-976, 1991
9. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R: Increased plasma Levels of immunoreactive endothelin and vpn Willebrand factor in NIDDM patiens. Diabetes Care 18: 87-89, 1995
10. Kamoi K, Ishibashi M, Yamaji T: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy. Diabetes Res and Clin Pract 24: 125-129, 1994
11. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463, 1989
12. Hasunuma K, Yamada K, Tamura T, Yoshida S: Cardiovascular and renin responses to desmopressin in humans: role of prostacyclin and β-adrenergic systems. Am J Physiol 260 (Heart Circ. Physiol. 29): H1031-H1036, 1991
13. Yamada K, Nakayama M, Nakano H, Mimura N, Yoshida S: Endothelium-dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta. Am J Physiol 264: E203-E207, 1993
14. Nakayama M, Yamada K, Yamamoto Y, Yokayama K, Nakano H, Kubo H, Shigematu T, Kawaguti Y, Sakai O: Vascular endothelial dysfunction in patients on regular dialysis treatment. Cli Nephrol 42: 117-120, 1994
15. Mannucci PM, Canciani MT, Rota L, Donovan BS: Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with heamophilia A and von Willebrand's disease. Br J Haematol 47: 283-293, 1981
16. Richardson DW, Robinson AG: Desmopressin. Ann Intern Med 103: 228-239, 1985
17. Kobrinsky NL, Doyle JJ, Israels ED, Winter JS, Cheang MS, Walker RD, Bishop AJ: Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrotic diabetes insipidus. Lancet 1: 1293-1294, 1985
18. Hamsten A, Wiman B, de Faire U, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557-1563, 1985
19. Paramo JA, Colucci M, Collen D, van de Werl F: Plasminogen activator inhibitor in the blood of patients with coronary disease. Br Med J Clin Res Ed 291: 573-574, 1985
20. Murad F: Cyclic guanosine monophosphate as a mediator of vasolilation. J Clin Invest 78: 1-5, 1986
21. Ness PM, Perkins HA: A simple enzyme immunoassay (EIA) test for factor VIII-related antigen (VIII AGN). Thromb Haemostas (Stuttg.) 42: 848-854, 1979
22. Yamada K, Nakano H, Nakayama M, Nozaki O, Miura Y, Nishimura M, Tsuchida H, Mimura N: Endothelium-dependent in peripheral vasculature and kidney of non-insulin-dependent diabetes mellitus. J Diab Comp 9: 203-207, 1995
23. Jaffe EA, Hoyer LW, Nachman RL: Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71: 1906-1909, 1974
24. Sasaki T, Kurata H, Nomura K, Utsunomiya K, Ikeda Y: Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 29: 156-163, 1990